Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia

Affiliations

• ¹ Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, USA.
• ² Department of Medicine, Stanford University, Stanford, California, USA.
• ³ Department of Medicine, University of California, Davis, California, USA.
• ⁴ Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, California, USA.
• ⁵ Section of Hematology/Oncology, Department of Medicine, University of Oklahoma, Oklahoma City, Oklahoma, USA.
• ⁶ Division of Hematology/Oncology, Department of Medicine, University of California, Davis, California, USA.
• ⁷ Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, California, USA.
• ⁸ Division of Hematology, Department of Medicine, Stanford University, Stanford, California, USA.